121 related articles for article (PubMed ID: 3806620)
1. Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters.
Musser JH; Kubrak DM; Chang J; DiZio SM; Hite M; Hand JM; Lewis AJ
J Med Chem; 1987 Feb; 30(2):400-5. PubMed ID: 3806620
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
Musser JH; Kubrak DM; Chang J; Lewis AJ
J Med Chem; 1986 Aug; 29(8):1429-35. PubMed ID: 3090264
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors.
Kees KL; Musser JH; Chang J; Skowronek M; Lewis AJ
J Med Chem; 1986 Nov; 29(11):2329-34. PubMed ID: 2878078
[TBL] [Abstract][Full Text] [Related]
4. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.
Musser JH; Chakraborty UR; Sciortino S; Gordon RJ; Khandwala A; Neiss ES; Pruss TP; Van Inwegen R; Weinryb I; Coutts SM
J Med Chem; 1987 Jan; 30(1):96-104. PubMed ID: 3806607
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonists.
Kreft AF; Klaubert DH; Bell SC; Pattison TW; Yardley JP; Carlson RP; Hand JM; Chang JY; Lewis AJ
J Med Chem; 1986 Jul; 29(7):1134-8. PubMed ID: 3806566
[TBL] [Abstract][Full Text] [Related]
6. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J
J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
[TBL] [Abstract][Full Text] [Related]
7. Substituted (aryloxy)alkanoic acids as antagonists of slow-reacting substance of anaphylaxis.
LeMahieu RA; Carson M; Han RJ; Nason WC; O'Donnell M; Brown DL; Crowley HJ; Welton AF
J Med Chem; 1987 Jan; 30(1):173-8. PubMed ID: 3027332
[TBL] [Abstract][Full Text] [Related]
8. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
Musser JH; Kreft AF; Bender RH; Kubrak DM; Carlson RP; Chang J; Hand JM
J Med Chem; 1989 Jun; 32(6):1176-83. PubMed ID: 2498516
[TBL] [Abstract][Full Text] [Related]
9. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
10. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists.
Dillard RD; Hahn RA; McCullough D; Carr FP; Rinkema LE; Roman CR; Fleisch JH
J Med Chem; 1991 Sep; 34(9):2768-78. PubMed ID: 1654427
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of 5-lipoxygenase by RG 6866.
Carnathan GW; Sweeney DM; Travis JJ; Gordon RJ; Sutherland CA; Jariwala N; Clearfield M; O'Rourke S; Huang FC; Van Inwegen RG
Agents Actions; 1989 Nov; 28(3-4):204-11. PubMed ID: 2596372
[TBL] [Abstract][Full Text] [Related]
12. Phenylephrine derivatives as leukotriene D4 antagonists.
Musser JH; Kubrak DM; Bender RH; Kreft AF; Nielsen ST; Lefer AM; Chang J; Lewis AJ; Hand JM
J Med Chem; 1987 Nov; 30(11):2087-93. PubMed ID: 3669017
[TBL] [Abstract][Full Text] [Related]
13. The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
Rokach J; Young RN
Adv Exp Med Biol; 1989; 259():75-108. PubMed ID: 2560345
[No Abstract] [Full Text] [Related]
14. N-(heterocyclic alkyl)pyrido[2,1-b]quinazoline-8-carboxamides as orally active antiallergy agents.
Tilley JW; Levitan P; Lind J; Welton AF; Crowley HJ; Tobias LD; O'Donnell M
J Med Chem; 1987 Jan; 30(1):185-93. PubMed ID: 2879917
[TBL] [Abstract][Full Text] [Related]
15. Arachidonate 5-lipoxygenase and its new inhibitors.
Yamamoto S; Yoshimoto T; Furukawa M; Horie T; Watanabe-Kohno S
J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):349-52. PubMed ID: 6432877
[TBL] [Abstract][Full Text] [Related]
16. Anti-leukotriene effects of WY-50,295 tromethamine in isolated guinea pig pulmonary tissues.
Heaslip RJ; Grimes D; Berkenkopf JW; Ilsemann BA; Sickels BD; Weichman BM
Eur J Pharmacol; 1993 Apr; 234(2-3):247-54. PubMed ID: 8482329
[TBL] [Abstract][Full Text] [Related]
17. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.
Bhattacherjee P; Boughton-Smith NK; Follenfant RL; Garland LG; Higgs GA; Hodson HF; Islip PJ; Jackson WP; Moncada S; Payne AN
Ann N Y Acad Sci; 1988; 524():307-20. PubMed ID: 2837965
[TBL] [Abstract][Full Text] [Related]
18. Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.
Musser JH; Kubrak DM; Chang J; Lewis AJ
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():536-9. PubMed ID: 2959109
[No Abstract] [Full Text] [Related]
19. Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224.
Lau CK; Bélanger PC; Scheigetz J; Dufresne C; Williams HW; Maycock AL; Guindon Y; Bach T; Dallob AL; Denis D
J Med Chem; 1989 Jun; 32(6):1190-7. PubMed ID: 2542553
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257).
Sun FF; McGuire JC
Prostaglandins; 1983 Aug; 26(2):211-21. PubMed ID: 6417727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
